by SMG Support | Mar 3, 2026 | Biotech Consulting, GMP Good Manufacturing Practices, Insights
Common GMP Mistakes That Lead to Form 483 Observations For biotech and pharmaceutical companies, Good Manufacturing Practice (GMP) compliance is non-negotiable. A Form 483 from the U.S. Food and Drug Administration can significantly disrupt operations, delay product...
by SMG Support | Mar 3, 2026 | Biopharma Consultant, Insights, Uncategorized
Why Pharma Quality Control is Critical for Patient Safety In the pharmaceutical industry, patient safety is the highest priority. Every medication, biologic, or therapeutic product must meet strict standards before reaching healthcare providers and patients. This is...
by SMG Support | Mar 3, 2026 | Insights, Pharma Consulting
Method Validation vs. Method Verification: What’s the Difference? A Pharma Consulting Perspective In regulated life sciences environments, analytical methods must be proven reliable, reproducible, and compliant. Yet many biotech and pharmaceutical companies struggle...
